Accordingly, it was shown that the expression of ORF1p is higher in cancers with TP53 mutations (Figure 4A), suggesting that TP53 is a critical tumor suppressor gate to prevent LINE-1-induced genotoxic stress. This evidence concerns the gene TP53 and cancer.